Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

Investor Network: GenMark Diagnostics, Inc. to Host Earnings Call

Accesswire May 2, 2017

GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Fungal Pathogen Panel

Business Wire April 20, 2017

GenMark Diagnostics to Present at 16th Annual Needham Healthcare Conference

Business Wire March 28, 2017

GenMark Diagnostics to Present at Cowen and Company’s 37th Annual Health Care Conference

Business Wire March 2, 2017

GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results

Business Wire February 28, 2017

GenMark Diagnostics Schedules Fourth Quarter 2016 Financial Results Conference Call for February 28, 2017

Business Wire February 9, 2017

GenMark Announces Preliminary Q4 2016 Financial Results

Business Wire January 10, 2017

GenMark Diagnostics to Present at the 2017 J.P. Morgan Healthcare Conference

Business Wire December 28, 2016

GenMark Diagnostics Submits 510(k) Applications to the FDA for ePlex® Sample-to-Answer Instrument and Respiratory Pathogen Panel

Business Wire December 22, 2016

GenMark Diagnostics Reports Q3 Financial Results

Business Wire November 3, 2016

GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Business Wire November 1, 2016

Mid-Afternoon Market Update: Dow Falls 100 Points; Crude Oil Down 2.3%

Benzinga.com  September 16, 2016

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  September 16, 2016

Mid-Day Market Update: Novavax Tumbles Following Failed Trial; Depomed Shares Surge

Benzinga.com  September 16, 2016

Mid-Morning Market Update: Markets Open Lower; Intel Lifts Q3 Revenue Outlook

Benzinga.com  September 16, 2016

GenMark Diagnostics Reports Q2 Financial Results

Business Wire July 28, 2016

GenMark Diagnostics to Present at the 36th Annual Canaccord Genuity Growth Conference

Business Wire July 27, 2016

GenMark Diagnostics Schedules Second Quarter 2016 Financial Results Conference Call for July 28, 2016

Business Wire July 14, 2016

GenMark Achieves CE Mark for its ePlex® Sample-to-Answer System

Business Wire June 8, 2016

GenMark Diagnostics to Present at the William Blair 36th Annual Growth Stock Conference

Business Wire June 6, 2016